BiotechTube
Home/Owl Therapeutics/Franklin Okumu
FO

Franklin Okumu

Co-Founder & CTO

Owl Therapeutics

Therapeutic Areas

NeurologyNeurodegenerative DiseasesTraumatic Brain Injury

Owl Therapeutics Pipeline

DrugIndicationPhase
NeuroSTAT® (OWL-1410)Traumatic Brain Injury (TBI)Pre-clinical
AI-engineered candidatesAlzheimer's DiseasePre-clinical

Leadership Team at Owl Therapeutics

WH
William Haskins
Co-Founder & CEO
HL
Henry Lowman
Co-Founder & Technical Advisor
TK
Todd Kilbaugh
Co-Founder & Clinical Advisor
View full Owl Therapeutics profile